<SEC-DOCUMENT>0000902664-25-004624-index.html : 20251029 <SEC-HEADER>0000902664-25-004624.hdr.sgml : 20251029 <ACCEPTANCE-DATETIME>20251029172957 ACCESSION NUMBER: 0000902664-25-004624 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20251029 DATE AS OF CHANGE: 20251029 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TENAX THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000034956 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 262593535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-58467 FILM NUMBER: 251431213 BUSINESS ADDRESS: STREET 1: 101 GLEN LENNOX DRIVE STREET 2: SUITE 300 CITY: CHAPEL HILL STATE: NC ZIP: 27517 BUSINESS PHONE: 919-855-2100 MAIL ADDRESS: STREET 1: 101 GLEN LENNOX DRIVE STREET 2: SUITE 300 CITY: CHAPEL HILL STATE: NC ZIP: 27517 FORMER COMPANY: FORMER CONFORMED NAME: OXYGEN BIOTHERAPEUTICS, INC. DATE OF NAME CHANGE: 20080703 FORMER COMPANY: FORMER CONFORMED NAME: SYNTHETIC BLOOD INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SINEQUANON CORP DATE OF NAME CHANGE: 19901219 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Point72 Asset Management, L.P. CENTRAL INDEX KEY: 0001603466 ORGANIZATION NAME: EIN: 465064661 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-890-2000 MAIL ADDRESS: STREET 1: 72 CUMMINGS POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 </SEC-HEADER> <DOCUMENT> <TYPE>SCHEDULE 13G <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>p25-2311exhibit99_1.htm <DESCRIPTION>JOINT FILING AGREEMENT <TEXT> Document 2 - file: p25-2311exhibit99_1.htm
</DOCUMENT> </SEC-DOCUMENT>